{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T02:05:08Z","timestamp":1792807508503,"version":"4.5.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.vaccine.2015.04.028","type":"journal-article","created":{"date-parts":[[2015,4,19]],"date-time":"2015-04-19T00:00:20Z","timestamp":1429401620000},"page":"C55-C61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"special_numbering":"S3","title":["Typhoid fever vaccination strategies"],"prefix":"10.1016","volume":"33","author":[{"given":"Kashmira A.","family":"Date","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adwoa","family":"Bentsi-Enchill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1448-8839","authenticated-orcid":false,"given":"Kimberley","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.vaccine.2015.04.028_bib0230","doi-asserted-by":"crossref","first-page":"e570","DOI":"10.1016\/S2214-109X(14)70301-8","article-title":"Burden of typhoid fever in low-income and middle-income countries: a systematic, literature-based update with risk-factor adjustment","volume":"2","author":"Mogasale","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/j.vaccine.2015.04.028_bib0235","article-title":"Typhoid fever","author":"Wain","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2015.04.028_bib0240","series-title":"Tropical infectious diseases: principles, pathogens and practice.","first-page":"121","article-title":"Typhoid and paratyphoid (enteric) fever","author":"Levine","year":"2011"},{"issue":"22","key":"10.1016\/j.vaccine.2015.04.028_bib0245","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJMra020201","article-title":"Typhoid fever","volume":"347","author":"Parry","year":"2002","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.vaccine.2015.04.028_bib0250","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1086\/503033","article-title":"Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal","volume":"42","author":"Maskey","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"5","key":"10.1016\/j.vaccine.2015.04.028_bib0255","first-page":"346","article-title":"The global burden of typhoid fever","volume":"82","author":"Crump","year":"2004","journal-title":"Bull World Health Organ"},{"issue":"2","key":"10.1016\/j.vaccine.2015.04.028_bib0260","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1086\/649541","article-title":"Global trends in typhoid and paratyphoid Fever","volume":"50","author":"Crump","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.vaccine.2015.04.028_bib0265","doi-asserted-by":"crossref","first-page":"4315","DOI":"10.1128\/AAC.00294-07","article-title":"Antimicrobial drug resistance of Salmonella enterica serovar Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones","volume":"51","author":"Chau","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.vaccine.2015.04.028_bib0270","series-title":"Control of communicable diseases manual","author":"Heymann","year":"2014"},{"key":"10.1016\/j.vaccine.2015.04.028_bib0275","series-title":"Typhoid vaccines","author":"World Health Organization (WHO)","year":"2008"},{"issue":"39","key":"10.1016\/j.vaccine.2015.04.028_bib0280","first-page":"855","article-title":"Typhoid fever surveillance and vaccine use \u2013 South-East Asia and Western Pacific regions, 2009\u20132013","volume":"63","author":"Date","year":"2014","journal-title":"Morb Mortal Wkly Rep"},{"issue":"4","key":"10.1016\/j.vaccine.2015.04.028_bib0285","doi-asserted-by":"crossref","first-page":"903","DOI":"10.4161\/hv.23007","article-title":"Vaccination for typhoid fever in sub-Saharan Africa","volume":"9","author":"Slayton","year":"2013","journal-title":"Hum Vaccine Immunother"},{"issue":"4","key":"10.1016\/j.vaccine.2015.04.028_bib0290","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1056\/NEJMoa0807521","article-title":"A cluster-randomized effectiveness trial of Vi typhoid vaccine in India","volume":"361","author":"Sur","year":"2009","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.vaccine.2015.04.028_bib0295","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/0264-410X(95)00186-5","article-title":"Immunogenicity, efficacy and serological correlate of protection of Salmonella Typhi Vi capsular polysaccharide vaccine three years after immunization","volume":"14","author":"Klugman","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.04.028_bib0300","series-title":"Immunological basis of immunization series: module 20: Salmonella enterica serovar Typhi (typhoid) vaccines. Geneva","author":"World Health Organization (WHO)","year":"2011"},{"issue":"11","key":"10.1016\/j.vaccine.2015.04.028_bib0305","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1586\/14760584.2013.845529","article-title":"Development of Vi conjugate \u2013 a new generation of typhoid vaccine","volume":"12","author":"Szu","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.04.028_bib0310","series-title":"Expert consultation to review evidence in support of the use of typhoid conjugate vaccines","author":"World Health Organization (WHO)","year":"2014"},{"issue":"5","key":"10.1016\/j.vaccine.2015.04.028_bib0315","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1128\/CVI.00532-10","article-title":"The Vi conjugate typhoid vaccine is safe, elicits protective levels of IgG anti-Vi, and is compatible with routine infant vaccines","volume":"18","author":"Thiem","year":"2011","journal-title":"Clin Vaccine Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2015.04.028_bib0320","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1473-3099(13)70241-X","article-title":"Immunogenicity and safety of the Vi-CRM197 conjugate vaccine against typhoid fever in adults, children, and infants in south and southeast Asia: results from two randomised, observer-blind, age de-escalation, phase 2 trials","volume":"14","author":"Bhutta","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"17","key":"10.1016\/j.vaccine.2015.04.028_bib0325","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1056\/NEJM200104263441701","article-title":"The efficacy of a Salmonella typhi Vi conjugate vaccine in two-to-five-year-old children","volume":"344","author":"Lin","year":"2001","journal-title":"N Engl J Med"},{"issue":"14","key":"10.1016\/j.vaccine.2015.04.028_bib0330","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1056\/NEJM200310023491423","article-title":"Persistent efficacy of Vi conjugate vaccine against typhoid fever in young children","volume":"349","author":"Mai","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2015.04.028_bib0335","unstructured":"Government of Western Australia \u2013 Department of Health. Food handlers. Available at: http:\/\/ww2.health.wa.gov.au\/Corporate\/Articles\/F_I\/Food-handlers [accessed 16.02.15]."},{"issue":"5","key":"10.1016\/j.vaccine.2015.04.028_bib0340","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1586\/erv.10.43","article-title":"Population impact of Vi capsular polysaccharide vaccine","volume":"9","author":"Khan","year":"2010","journal-title":"Expert Rev Vaccines"},{"issue":"5","key":"10.1016\/j.vaccine.2015.04.028_bib0345","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1586\/14760584.7.5.547","article-title":"Typhoid vaccination: the Asian experience","volume":"7","author":"DeRoeck","year":"2008","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2015.04.028_bib0350","series-title":"The 8th International Conference on Typhoid Fever and Other Invasive Salmonelloses","article-title":"Community-based typhoid vaccination program in New Delhi, India","author":"Dewan","year":"2013"},{"issue":"May","key":"10.1016\/j.vaccine.2015.04.028_bib0355","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2458-5-49","article-title":"A mass vaccination campaign targeting adults and children to prevent typhoid fever in Hechi; expanding the use of Vi polysaccharide vaccine in southeast China: a cluster-randomized trial","volume":"5","author":"Yang","year":"2005","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2015.04.028_bib0360","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1745-6215-7-17","article-title":"Lessons and implications from a mass immunization campaign in squatter settlements of Karachi, Pakistan: an experience from a cluster-randomized double-blinded vaccine trial [NCT00125047]","volume":"7","author":"Khan","year":"2006","journal-title":"Trials"},{"issue":"50","key":"10.1016\/j.vaccine.2015.04.028_bib0365","doi-asserted-by":"crossref","first-page":"6305","DOI":"10.1016\/j.vaccine.2008.09.040","article-title":"The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries","volume":"26","author":"Cook","year":"2008","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2015.04.028_bib0370","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.4269\/ajtmh.13-0728","article-title":"Impact of a targeted typhoid vaccination campaign following cyclone Tomas, Republic of Fiji, 2010","volume":"90","author":"Scobie","year":"2014","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2015.04.028_bib0375","series-title":"Typhoid vaccine use in countries \u2013 progress and challenges","author":"Namgyal","year":"2010"},{"issue":"4","key":"10.1016\/j.vaccine.2015.04.028_bib0380","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/infdis\/159.4.766","article-title":"Comparative efficacy of two, three, or four doses of Ty21a live oral typhoid vaccine in enteric-coated capsules: a field trial in an endemic area","volume":"159","author":"Ferreccio","year":"1989","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2015.04.028_bib0385","doi-asserted-by":"crossref","first-page":"C62","DOI":"10.1016\/j.vaccine.2015.03.087","article-title":"Typhoid vaccine introduction: an evidence-based pilot implementation project in Nepal and Pakistan","volume":"33","author":"Khan","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2015.04.028_bib0390","first-page":"515","article-title":"The feasibility of a school-based Vi polysaccharide vaccine mass immunization campaign in Hue City, central Vietnam: streamlining a typhoid fever preventive strategy","volume":"37","author":"Thiem","year":"2006","journal-title":"Southeast Asian J Trop Med Public Health"},{"issue":"11","key":"10.1016\/j.vaccine.2015.04.028_bib0395","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.puhe.2006.06.008","article-title":"Introducing Vi polysaccharide typhoid fever vaccine to primary school children in North Jakarta, Indonesia, via an existent school-based vaccination platform","volume":"120","author":"Agtini","year":"2006","journal-title":"Public Health"},{"key":"10.1016\/j.vaccine.2015.04.028_bib0400","series-title":"Post Cyclone Tomas support to typhoid fever control in Fiji: report to AusAID. Fiji Health Sector Improvement Program","author":"Jenkins","year":"2011"},{"issue":"1","key":"10.1016\/j.vaccine.2015.04.028_bib0405","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4269\/ajtmh.1999.61.163","article-title":"Considerations regarding mass vaccination against typhoid fever as an adjunct to sanitation and public health measures: potential use in an epidemic in Tajikistan","volume":"61","author":"Tarr","year":"1999","journal-title":"Am J Trop Med Hyg"},{"issue":"12","key":"10.1016\/j.vaccine.2015.04.028_bib0410","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1086\/320729","article-title":"An outbreak of typhoid fever, Xing-An County, People's Republic of China, 1999: estimation of the field effectiveness of Vi polysaccharide typhoid vaccine","volume":"183","author":"Yang","year":"2001","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.vaccine.2015.04.028_bib0415","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.vaccine.2013.11.070","article-title":"Literature review of HPV vaccine delivery strategies: considerations for school- and non-school based immunization program","volume":"32","author":"Paul","year":"2014","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2015.04.028_bib0420","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1080\/10810730.2012.727958","article-title":"Formative research and development of an evidence-based communication strategy: the introduction of Vi typhoid fever vaccine among school-aged children in Karachi, Pakistan","volume":"18","author":"Pach","year":"2013","journal-title":"J Health Commun"},{"key":"10.1016\/j.vaccine.2015.04.028_bib0425","series-title":"Considerations regarding consent in vaccinating children and adolescents between 6 and 17 years old","author":"World Health Organization (WHO)","year":"2014"},{"issue":"42","key":"10.1016\/j.vaccine.2015.04.028_bib0430","doi-asserted-by":"crossref","first-page":"6047","DOI":"10.1016\/j.vaccine.2012.07.051","article-title":"Cross-reactive gut-directed immune response against Salmonella enterica serovar Paratyphi A and B in typhoid fever and after oral Ty21a typhoid vaccination","volume":"30","author":"Pakkanen","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2015.04.028_bib0435","first-page":"S8","article-title":"Ty21a live oral typhoid vaccine and prevention of paratyphoid fever caused by Salmonella enterica serovar Paratyphi B","volume":"45","author":"Levine","year":"2007","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2015.04.028_bib0440","doi-asserted-by":"crossref","first-page":"e2642","DOI":"10.1371\/journal.pntd.0002642","article-title":"Predicting the impact of vaccination on the transmission dynamics of typhoid in South Asia: a mathematical modeling study","volume":"8","author":"Pitzer","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.04.028_bib0445","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2015.02.027","article-title":"Economic evaluation of typhoid vaccination in a prolonged typhoid outbreak setting: the case of Kasese district in Uganda","author":"Carias","year":"2015","journal-title":"Vaccine"},{"issue":"6","key":"10.1016\/j.vaccine.2015.04.028_bib0450","doi-asserted-by":"crossref","first-page":"e101114","DOI":"10.1371\/journal.pone.0101114","article-title":"Costs of introducing and delivering HPV vaccines in low and lower middle income countries: inputs for GAVI policy on introduction grant support to countries","volume":"9","author":"Levin","year":"2014","journal-title":"PLOS ONE"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15004818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15004818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T15:48:30Z","timestamp":1566575310000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15004818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":45,"alternative-id":["S0264410X15004818"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.028","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Typhoid fever vaccination strategies","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.04.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}